Long-term outcomes of pulmonary embolism in children and adolescents

Denise Bastas1, Leonardo R Brandão1,2, Jennifer Vincelli2

  • 1Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.

Blood
|December 22, 2023
PubMed

Insights

Long-term consequences of pulmonary embolism (PE) in children are significant, with many experiencing functional impairments. Underlying conditions increase risks, emphasizing the need for physical activity promotion post-PE.

Area of Science:

  • Pediatric Pulmonology
  • Cardiovascular Research
  • Clinical Outcomes

Background:

  • Limited knowledge exists on the long-term effects of pulmonary embolism (PE) in pediatric populations.
  • Understanding these outcomes is crucial for developing effective follow-up protocols.

Purpose of the Study:

  • To describe the long-term outcomes of pediatric pulmonary embolism (PE).
  • To compare outcomes between children with and without underlying conditions.
  • To identify factors influencing functional recovery after PE.

Main Methods:

  • A cohort study followed 150 children diagnosed with PE (age 0-18 years) for at least 6 months.
  • Follow-up included clinical evaluation, imaging, echocardiography, pulmonary function tests, and cardiopulmonary exercise tests.
  • Outcomes assessed were PE resolution, recurrence, death, and functional impairments.

Main Results:

  • Pulmonary embolism (PE) resolved in 71% of children; 9% experienced recurrence, and 5% died.
  • One-third had transient functional impairments, including ventilatory issues (31%) and reduced aerobic capacity (31%).
  • Underlying conditions were linked to higher recurrence, pulmonary impairments, and poorer exercise capacity.

Conclusions:

  • Pediatric pulmonary embolism (PE) can lead to persistent functional deficits, though most abnormalities are transient.
  • Underlying conditions significantly impact PE recurrence and functional recovery.
  • Exercise intolerance post-PE is often due to deconditioning, underscoring the importance of physical activity.

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
155
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
176
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K